Condition Lookup
Category:
Uncommon RBC Membrane Disorders
Number of Conditions: 4
Hereditary Elliptocytosis
Specialty: Hematology
Category: Uncommon RBC Membrane Disorders
Symptoms:
fatigue; pallor; jaundice; splenomegaly; mild anemia; increased elliptically-shaped red blood cells on blood smear
Root Cause:
Mutations in genes encoding cytoskeletal proteins (such as spectrin or protein 4.1) lead to weakened red blood cell membranes and elliptical shapes.
How it's Diagnosed: videos
Peripheral blood smear showing elliptocytes; osmotic fragility test; genetic testing for cytoskeletal protein mutations.
Treatment:
Typically supportive care; splenectomy in severe cases to reduce hemolysis.
Medications:
No direct medications; folic acid supplementation may be recommended to support red blood cell production.
Prevalence:
How common the health condition is within a specific population.
Estimated prevalence of 1 in 2,000–5,000 individuals, more common in populations with African or Mediterranean ancestry.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Family history, genetic predisposition.
Prognosis:
The expected outcome or course of the condition over time.
Generally good; most cases are asymptomatic or mild. Severe cases may lead to chronic hemolytic anemia requiring intervention.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Gallstones, splenomegaly, severe anemia, aplastic crisis during infections (e.g., parvovirus B19).
Hereditary Pyropoikilocytosis
Specialty: Hematology
Category: Uncommon RBC Membrane Disorders
Symptoms:
severe anemia; jaundice; splenomegaly; fatigue; fragmented red blood cells on blood smear; extreme red cell sensitivity to heat
Root Cause:
A severe form of hereditary elliptocytosis caused by significant mutations in cytoskeletal proteins, leading to extreme red cell fragility and thermal sensitivity.
How it's Diagnosed: videos
Peripheral blood smear showing schistocytes and elliptocytes; osmotic fragility test; thermal sensitivity test; genetic analysis.
Treatment:
Supportive care, regular blood transfusions in severe cases, and splenectomy to reduce hemolysis.
Medications:
No direct medications; folic acid supplementation is commonly used.
Prevalence:
How common the health condition is within a specific population.
Rare; exact prevalence unknown, but often diagnosed in individuals of African descent.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Family history, inheritance of specific genetic mutations.
Prognosis:
The expected outcome or course of the condition over time.
Variable; severe cases may require lifelong management of anemia. Splenectomy can improve symptoms.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Severe hemolytic anemia, gallstones, increased susceptibility to infections post-splenectomy.
Hereditary Spherocytosis
Specialty: Hematology
Category: Uncommon RBC Membrane Disorders
Symptoms:
anemia; jaundice; splenomegaly; fatigue; shortness of breath; spherocytes on blood smear
Root Cause:
Mutations in genes encoding membrane proteins (such as ankyrin, spectrin, or band 3) cause red blood cells to lose their biconcave shape and become spherical, leading to reduced deformability and increased hemolysis.
How it's Diagnosed: videos
Peripheral blood smear, osmotic fragility test, eosin-5-maleimide binding test (flow cytometry).
Treatment:
Folic acid supplementation, splenectomy in severe cases, and blood transfusions for acute anemia.
Medications:
No specific medications; supportive care includes folic acid and, in rare cases, erythropoiesis-stimulating agents.
Prevalence:
How common the health condition is within a specific population.
1 in 2,000–5,000 individuals, more common in Northern European populations.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Family history, genetic inheritance.
Prognosis:
The expected outcome or course of the condition over time.
Good with appropriate management; splenectomy often resolves anemia.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Gallstones, aplastic crisis during infections, post-splenectomy sepsis.
Spur Cell Anemia
Specialty: Hematology
Category: Uncommon RBC Membrane Disorders
Symptoms:
fatigue; jaundice; splenomegaly; severe anemia; irregularly spiked red blood cells (acanthocytes) on blood smear
Root Cause:
Alterations in red blood cell membrane lipids, often secondary to liver disease, lead to the formation of spiked red blood cells (acanthocytes) that are prone to splenic destruction.
How it's Diagnosed: videos
Blood smear showing acanthocytes; liver function tests; assessment of underlying liver disease (e.g., cirrhosis).
Treatment:
Management of underlying liver disease, supportive care, and blood transfusions in severe cases.
Medications:
No direct medications; treatment focuses on managing liver disease (e.g., diuretics, albumin , or treatments for liver failure).
Prevalence:
How common the health condition is within a specific population.
Rare; associated with advanced liver disease, particularly cirrhosis.
Risk Factors:
Factors or behaviors that increase the likelihood of developing the condition.
Chronic liver disease, alcoholism, malnutrition.
Prognosis:
The expected outcome or course of the condition over time.
Poor if underlying liver disease is advanced; anemia may improve with liver transplantation.
Complications:
Additional problems or conditions that may arise as a result of the original condition.
Severe anemia, hepatic encephalopathy, multiorgan failure.